rs16856530

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004525.3(LRP2):​c.12151+585A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.787 in 151,742 control chromosomes in the GnomAD database, including 47,456 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.79 ( 47456 hom., cov: 32)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.363

Publications

2 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • congenital heart disease
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.871 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.12151+585A>G
intron
N/ANP_004516.2P98164

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.12151+585A>G
intron
N/AENSP00000496870.1P98164
LRP2
ENST00000649153.1
n.3049+585A>G
intron
N/AENSP00000497617.1A0A3B3IT64
LRP2
ENST00000650252.1
n.1183+585A>G
intron
N/AENSP00000496887.1A0A3B3IRR0

Frequencies

GnomAD3 genomes
AF:
0.787
AC:
119313
AN:
151624
Hom.:
47407
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.878
Gnomad AMI
AF:
0.722
Gnomad AMR
AF:
0.803
Gnomad ASJ
AF:
0.735
Gnomad EAS
AF:
0.493
Gnomad SAS
AF:
0.856
Gnomad FIN
AF:
0.713
Gnomad MID
AF:
0.856
Gnomad NFE
AF:
0.760
Gnomad OTH
AF:
0.782
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.787
AC:
119423
AN:
151742
Hom.:
47456
Cov.:
32
AF XY:
0.785
AC XY:
58204
AN XY:
74156
show subpopulations
African (AFR)
AF:
0.878
AC:
36366
AN:
41410
American (AMR)
AF:
0.803
AC:
12250
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.735
AC:
2541
AN:
3458
East Asian (EAS)
AF:
0.494
AC:
2543
AN:
5146
South Asian (SAS)
AF:
0.854
AC:
4116
AN:
4820
European-Finnish (FIN)
AF:
0.713
AC:
7495
AN:
10506
Middle Eastern (MID)
AF:
0.855
AC:
248
AN:
290
European-Non Finnish (NFE)
AF:
0.760
AC:
51562
AN:
67848
Other (OTH)
AF:
0.784
AC:
1651
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1274
2548
3823
5097
6371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
860
1720
2580
3440
4300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.822
Hom.:
11583
Bravo
AF:
0.794
Asia WGS
AF:
0.721
AC:
2508
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
17
DANN
Benign
0.61
PhyloP100
-0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16856530; hg19: chr2-170012199; API